The US Supreme Court weighed the future of a key pathway that brings cheaper generic drugs to market sooner — a practice known as "skinny labeling" — Wednesday.
My story, on the case and what it means for consumers, in @statesnewsroom.com:
www.newsfromthestates.com/article/us-s...
www.newsfromthestates.com
By Zara Norman/Medill News ServiceWASHINGTON — John Bailey said he’s saved tens of thousands of dollars over the last decade by relying on a generic prescription to lower his cholesterol.The 68-year-o...
